Treatment for Severe Coronavirus Disease 2019 With the Seraph-100 Microbind Affinity Blood Filter
- 30 July 2020
- journal article
- case report
- Published by Wolters Kluwer Health in Critical Care Explorations
- Vol. 2 (8) , e0180
Abstract
Objectives: To determine whether Seraph-100 (Exthera Medical Corporation, Martinez, CA) treatment provides clinical benefit for severe coronavirus disease 2019 cases that require mechanical ventilation and vasopressor support. Data Sources: The first two patients in the United States treated with the novel Seraph-100 device. These cases were reviewed by the Food and Drug Administration prior to granting an emergency use authorization for treatment of coronavirus disease 2019. Study Selection: Case series. Data Extraction: Vasopressor dose, mean arterial pressure, temperature, interleukin-6, C-reactive protein, and other biomarker levels were documented both before and after Seraph-100 treatments. Data Synthesis: Vasopressor dose, temperature, interleukin-6, and C-reactive protein levels declined after Seraph-100 treatments. Severe acute respiratory syndrome coronavirus 2 viremia was confirmed in the one patient tested and cleared by the completion of treatments. Conclusions: Seraph-100 use may improve hemodynamic stability in coronavirus disease 2019 cases requiring mechanical ventilation and vasopressor support. These findings warrant future study of a larger cohort with the addition of mortality and total hospital day outcomes.Keywords
This publication has 21 references indexed in Scilit:
- Heparin 2.0: A New Approach to the Infection CrisisBlood Purification, 2020
- Viral dynamics in mild and severe cases of COVID-19The Lancet Infectious Diseases, 2020
- Extracorporeal Blood Purification and Organ Support in the Critically Ill Patient during COVID-19 Pandemic: Expert Review and RecommendationBlood Purification, 2020
- Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City AreaJAMA, 2020
- In vitro elimination of anti-infective drugs by the Seraph® 100 Microbind® affinity blood filterClinical Kidney Journal, 2020
- Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected PneumoniaNew England Journal of Medicine, 2020
- Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severityEmerging Microbes & Infections, 2020
- Viral RNA in Blood as Indicator of Severe Outcome in Middle East Respiratory Syndrome Coronavirus InfectionEmerging Infectious Diseases, 2016
- Cytokine Removal with High Cut-Off Membrane: Review of LiteratureBlood Purification, 2014
- Blood Purification and Mortality in SepsisCritical Care Medicine, 2013